Geode Capital Management
AIM

Geode Capital Management’s AIM ImmunoTech AIM Stock Holding History

Geode Capital Management’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5K Buy
29,918
+12,525
+72% +$12.7K ﹤0.01% 4464
2025
Q4 		$19.6K Buy
17,393
+1,191
+7% +$2.2K ﹤0.01% 4389
2025
Q3 		$44.3K Buy
+16,202
New +$72.5K ﹤0.01% 4319
2025
Q2 		– Sell
-5,319
Closed -$65K – 4593
2025
Q1 		$65K Buy
5,319
+674
+15% +$10.8K ﹤0.01% 4141
2024
Q4 		$91.9K Hold
4,645
– – ﹤0.01% 4116
2024
Q3 		$125K Buy
4,645
+631
+16% +$21K ﹤0.01% 4039
2024
Q2 		$150K Buy
4,014
+494
+14% +$21K ﹤0.01% 4011
2024
Q1 		$166K Hold
3,520
– – ﹤0.01% 4000
2023
Q4 		$155K Hold
3,520
– – ﹤0.01% 4027
2023
Q3 		$160K Sell
3,520
-293
-8% -$18.1K ﹤0.01% 4065
2023
Q2 		$255K Hold
3,813
– – ﹤0.01% 3932
2023
Q1 		$164K Hold
3,813
– – ﹤0.01% 4142
2022
Q4 		$118K Sell
3,813
-11
-0.3% -$511 ﹤0.01% 4340
2022
Q3 		$222K Hold
3,824
– – ﹤0.01% 4151
2022
Q2 		$297K Buy
3,824
+91
+2% +$8.73K ﹤0.01% 4034
2022
Q1 		$395K Hold
3,733
– – ﹤0.01% 4061
2021
Q4 		$343K Hold
3,733
– – ﹤0.01% 4230
2021
Q3 		$753K Buy
3,733
+212
+6% +$42.8K ﹤0.01% 3828
2021
Q2 		$756K Hold
3,521
– – ﹤0.01% 3736
2021
Q1 		$798K Buy
3,521
+1,169
+50% +$264K ﹤0.01% 3650
2020
Q4 		$420K Buy
2,352
+135
+6% +$27K ﹤0.01% 3641
2020
Q3 		$476K Buy
2,217
+668
+43% +$167K ﹤0.01% 3441
2020
Q2 		$383K Buy
+1,549
New +$376K ﹤0.01% 3464
2019
Q2 		– Sell
-17
Closed -$11K – 4306
2019
Q1 		$11K Hold
17
– – ﹤0.01% 4119
2018
Q4 		$13K Hold
17
– – ﹤0.01% 4123
2018
Q3 		$17K Hold
17
– – ﹤0.01% 4103
2018
Q2 		$23K Hold
17
– – ﹤0.01% 4038
2018
Q1 		$29K Hold
17
– – ﹤0.01% 3997
2017
Q4 		$25K Hold
17
– – ﹤0.01% 3987
2017
Q3 		$24K Hold
17
– – ﹤0.01% 4007
2017
Q2 		$37K Hold
17
– – ﹤0.01% 3997
2017
Q1 		$40K Hold
17
– – ﹤0.01% 3984
2016
Q4 		$51K Hold
17
– – ﹤0.01% 3910
2016
Q3 		$93K Hold
17
– – ﹤0.01% 3818
2016
Q2 		$103K Hold
17
– – ﹤0.01% 3797
2016
Q1 		$119 Hold
17
– – ﹤0.01% 3789
2015
Q4 		$72K Hold
17
– – ﹤0.01% 3950
2015
Q3 		$153K Hold
17
– – ﹤0.01% 3769
2015
Q2 		$183K Hold
17
– – ﹤0.01% 3613
2015
Q1 		$204K Hold
17
– – ﹤0.01% 3569
2014
Q4 		$224K Hold
17
– – ﹤0.01% 3540
2014
Q3 		$288K Buy
17
+2
+13% +$30.8K ﹤0.01% 3425
2014
Q2 		$240K Hold
15
– – ﹤0.01% 3460
2014
Q1 		$310K Buy
15
+4
+36% +$84.6K ﹤0.01% 3348
2013
Q4 		$149K Hold
11
– – ﹤0.01% 3507
2013
Q3 		$133K Hold
11
– – ﹤0.01% 3438
2013
Q2 		$126K Buy
+11
New +$131K ﹤0.01% 3371

Other funds holding AIM

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Geode Capital Management's AIM Position: Q1 2026 in Review

Geode Capital Management increased its AIM ImmunoTech (AIM) stake by 72% in Q1 2026, buying an estimated $12.7K and bringing the position to 29,918 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4464.

Geode Capital Management first reported a position in AIM in Q2 2013 and has held it in 47 quarters since. The position peaked at $798K in Q1 2021. 18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

  • Geode Capital Management held 29,918 shares of AIM ImmunoTech worth $17.5K as of Q1 2026.
  • Geode Capital Management bought 12,525 AIM ImmunoTech shares in Q1 2026, an estimated $12.7K.
  • AIM ImmunoTech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4464 holding.
  • Geode Capital Management first reported a position in AIM ImmunoTech in Q2 2013 and has held it in 47 quarters since.
  • Geode Capital Management's AIM ImmunoTech position peaked at $798K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.